biotech / news / / U.S. News & World Report
The justices turned away appeals by Novo Nordisk, AstraZeneca, Janssen Pharmaceuticals, Bristol Myers Squibb, Novartis and Boehringer Ingelheim.
The Supreme Court declined to hear drugmakers' challenge to Medicare drug price negotiations.
KEY POINTS
- Novo Nordisk, AstraZeneca, and other companies argued the plan violates constitutional protections.
- Lower courts had already rejected legal claims against the Inflation Reduction Act's price negotiation mandate.
- Despite lawsuits, Medicare's negotiated prices on 10 drugs went into effect this year.
- The mandatory negotiation requires drugmakers to comply or withdraw all drugs from Medicare programs.
COMPANIES
Summarized by Newsio from U.S. News & World Report. How we summarize →